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ABSTRACT
The African trypanosome Trypanosoma brucei is
a unicellular eukaryote, which relies on a protec-
tive variant surface glycoprotein (VSG) coat for sur-
vival in the mammalian host. A single trypanosome
has >2000 VSG genes and pseudogenes of which
only one is expressed from one of ∼15 telomeric
bloodstream form expression sites (BESs). Infec-
tious metacyclic trypanosomes present within the
tsetse fly vector also express VSG from a separate
set of telomeric metacyclic ESs (MESs). All MESs are
silenced in bloodstream form T. brucei. As very little
is known about how this is mediated, we performed
a whole genome RNAi library screen to identify MES
repressors. This allowed us to identify a novel SAP
domain containing DNA binding protein which we
called TbSAP. TbSAP is enriched at the nuclear pe-
riphery and binds both MESs and BESs. Knock-
down of TbSAP in bloodstream form trypanosomes
did not result in cells becoming more ‘metacyclic-
like’. Instead, there was extensive global upregula-
tion of transcripts including MES VSGs, VSGs within
the silent VSG arrays as well as genes immediately
downstream of BES promoters. TbSAP therefore ap-
pears to be a novel chromatin protein playing an im-
portant role in silencing the extensive VSG repertoire
of bloodstream form T. brucei.
INTRODUCTION
The African trypanosome Trypanosoma brucei (causative
agent of African Sleeping sickness) is an early-branching
unicellular eukaryote with highly unusual features to its
molecular biology (1). The T. brucei genome consists pri-
marily of extensive polycistronic transcription units con-
taining functionally unrelated assortments of genes which
are constitutively transcribed by RNA polymerase II (Pol
II) (2). The T. brucei genome encodes relatively few tran-
scription factors compared with other eukaryotes (3), which
is consistent with the observed general lack of Pol II tran-
scriptional regulation (4,5). Instead, regulation of mRNA
levels during the trypanosome life-cycle or in response to
stress, occurs primarily through post-transcriptional mech-
anisms including RNA stability mediated through sequence
elements located in mRNA untranslated regions (6).
The striking exception to this rule is the transcriptional
regulation of the vast number of T. brucei variant surface
glycoprotein (VSG) genes. T. brucei is an extracellular par-
asite of the mammalian bloodstream and tissue spaces (7,8).
Within the host, it is covered with a dense protective VSG
coat comprised of ∼107 molecules corresponding to ∼10%
total protein (9). A single trypanosome has a vast reper-
toire of thousands of VSG genes and pseudogenes, but only
one is transcribed at a time from one of 15 bloodstream
form VSG expression sites (BES) (10,11). BESs are telom-
eric transcription units with promoters located 30–60 kb
upstream of the telomeric VSG, and which include vari-
ous expression site associated genes (ESAGs) (12). Switch-
ing the active VSG entails replacement with another VSG
through DNA rearrangements including gene conversion,
or a transcriptional switch to a different BES (13–16).
A highly unusual feature of BES transcription is that it
is mediated by RNA polymerase I (Pol I) (17). This use of
Pol I for transcription of protein coding genes is unprece-
dented for a eukaryote, as Pol I normally exclusively tran-
scribes ribosomal DNA (rDNA) (18). Pol I transcription is
characterised by extremely high rates of transcription initia-
tion (19). This feature of Pol I appears to facilitate the ability
of the trypanosome to produce vast amounts of VSG tran-
script (about 10% total mRNA) from a single copy VSG
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gene. Pol I transcription of rDNA in eukaryotes is concen-
trated within a nuclear body referred to as the nucleolus
(20). This is also the case in T. brucei, but bloodstream form
trypanosomes additionally contain an extra-nucleolar Pol
I focus called the expression site body (ESB), where tran-
scription of the active BES occurs (21). Here, a highly strin-
gent mechanism of monoallelic expression operates, with
restricted access of the ESB to a single BES playing a key
role in this control (22).
However, inactive BESs are not the only ESs which are
kept silent in bloodstream form trypanosomes. T. brucei
is transmitted by tsetse flies, and the infectious metacyclic
stage present in the fly salivary glands is covered with a VSG
coat transcribed from one of several metacyclic expression
sites (MESs). MESs differ in architecture to BESs, with
MES promoters normally within 1–2 kb of the telomeric
VSG, compared with the 30–60 kb found in BESs (10,12).
In addition, MES promoters have divergent sequences com-
pared with BES promoters (23). However, both ES pro-
moter types are transcribed by Pol I, and are recognised by
the same CITFA Pol I transcription factor (24).
For antigenic variation to work, it is vital that both BESs
and MESs are kept silent in addition to the vast number
of VSG genes within the subtelomeric VSG arrays which
are not thought to be flanked by promoters. Little is known
about how all MESs are kept silent in bloodstream form T.
brucei. Promoter sequence alone is not sufficient to explain
MES silencing, as MES promoters can function in blood-
stream form T. brucei when present on episomes, but not
when they are in their native telomeric MES location (23).
We set out to identify factors playing a functional role in
silencing telomeric MESs in bloodstream form T. brucei.
To this end, we performed a whole genome RNAi library
screen selecting for derepression of a single inactive MES
marked with a drug resistance gene.
We did not identify known BES repressors, but discov-
ered a novel SAP DNA binding protein (TbSAP), which
plays an important role in MES repression. We found
that TbSAP is enriched at the T. brucei nuclear periph-
ery, and using ChIP, established that it binds MESs as well
as immediately upstream of BES promoters. Knockdown
of TbSAP resulted in extensive global upregulation of T.
brucei transcripts arguing that it has a general repressive
function. These derepressed transcripts included transcripts
from MES VSGs, VSGs within the silent VSG arrays, as well
as genes in the immediate region of BES promoters. TbSAP
therefore appears to be a novel chromatin protein with a key
functional role in repression of the extensive VSG repertoire
of bloodstream form T. brucei.
MATERIALS AND METHODS
Trypanosome strain generation and culturing
Bloodstream form (BF) Trypanosoma brucei strain 427 ex-
pressing VSG221 from BES1 (12) was used for all exper-
iments, and cultured in modified HMI-9 medium supple-
mented with 15% foetal calf serum. All cell lines used in
this study are detailed in Supplementary Table S1, and are
all based on the ‘single marker’ (SM) cell line (25) which
is referred to here as SM221. The SM221pur cell line has
a puromycin resistance gene inserted immediately behind
the BES1 promoter allowing selection for maintenance of
VSG221 expression (26). All genetically modified cell lines
were validated using linking PCR.
To mark an individual MES in BF T. brucei, constructs
were inserted downstream of the endogenous promoter of
MES VSG653 (10). The T. brucei SM221 MES-pur cell line
was generated by transfecting the pMES653PurBla plasmid
into SM221 cells resulting in a puromycin resistance gene
inserted downstream of the endogenous MES VSG653 pro-
moter. The T. brucei SM221 MES-GFP cell line was gen-
erated through the transfection of the pMES653eGFPBla
plasmid into T. brucei SM221 cells resulting in an eGFP
gene inserted downstream of the endogenous MES VSG653
promoter. In both cell lines, construct integration was se-
lected for using a blasticidin resistance driven by an ectopic
rDNA promoter. Both plasmids were generated by Gibson
assembly using the primers listed in Supplementary Table
S2.
T. brucei SM221pur Cas9 cells constitutively express-
ing Cas9 endonuclease were generated by transfecting the
pSMOx2 Cas9 plasmid (derived from a plasmid kindly pro-
vided by Jack Sunter, Oxford Brookes University, UK).
This integrates a codon-optimised Cas9 gene upstream of
the first -tubulin gene in the tubulin array, which is ex-
pressed by endogenous Pol II transcription. Cas9 mediated
gene tagging and gene knock-out were carried out as de-
scribed in (27). pPOT plasmids for this purpose were kindly
provided by Sam Dean, (University of Warwick, UK) and
primers were designed using the LeishGEedit website (www.
leishgedit.net). All plasmids and primers used for Cas9-
mediated gene tagging and knock-out are listed in Supple-
mentary Table S2.
Stem–loop RNAi constructs were generated by cloning a
PEX11 stuffer fragment flanked upstream by HindIII/XbaI
and downstream by BamHI/ AscI into pDexv4-mSt-
KIN17 (from the Bill Wickstead lab). A PEX11 stuffer
was cloned downstream of a tetracycline inducible T7 pro-
moter. Complementary gene sequences were cloned flank-
ing this PEX11 stuffer, and the construct was inserted into
the VSGG4 locus (Tb427VSG-31, Tb427 00805900) on a T.
brucei mini-chromosome (28) after digestion with NotI and
transfection into SM221pur cells.
All RNAi cell lines were generated from SM221pur
MES-GFP cells, with the exception of the -tubulin RNAi
cell line which was generated using T. brucei BNII V02+
pSMOx2. This cell line was generated using the BNII V02+
cell line (29) transfected with a derivative of the pSMOx
plasmid containing codon optimised tetracycline repressor
and T7 RNA polymerase (30) with alterations allowing con-
struct integration upstream of the first -tubulin gene of the
tubulin array (kind gift of Mark Carrington, University of
Cambridge, UK). PFR2 (Tb927.8.4970) was targeted for
RNAi using the first 400 bp of its CDS, TbSAP was tar-
geted for RNAi from position 130 to 634 of its CDS and
-tubulin was targeted for RNAi from position 629 to 1340
of its CDS.
RNAi library generation and selection for repressors of MES
transcription
The T. brucei SM221MES-pur cell line was transfected with
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the Sce* cassette, containing the I-SceI meganuclease and
its recognition site, from pRPaSce*(31) to the pRP construct
via HindIII/ Bsp120I cloning (32). In contrast to pRPaSce*,
which targets an ectopic rDNA spacer landing pad locus
in 2T1 T. brucei (32), pRPSce* is able to integrate at any of
the conserved rDNA spacer sequences in the SM221MES-
pur T. brucei cell line. Transformants were selected with hy-
gromycin.
pRPaSce* Hyg transfected cells were pooled for a total
number of ∼3 × 107 cells, and incubated for 24 h with-
out hygromycin before transfection of the T. brucei whole
genome RNAi plasmid library from (33). Transfection of
the plasmid RNAi library was performed after 3 h of tetra-
cycline induction to induce I-SceI expression and target site
cleavage, enabling high efficiency integration of the RNAi
library at the I-SceI cleaved rDNA spacer sequence (31).
Phleomycin was added 5 h after transfection to select for
RNAi library integration. T. brucei RNAi library cells were
counted daily and expanded continuously until total cell
number exceeded 1 × 108. Screens for repressors of MES
expression were initiated directly from expanded RNAi li-
brary cells using 2 × 107 cells per screen. The RNAi li-
brary was induced with tetracycline for 24 h to ensure robust
RNAi target depletion prior to addition of puromycin selec-
tion (50, 60 or 70 ng/ml). Genomic DNA for high through-
put RIT-seq analysis was harvested (Blood and Tissue Kit,
Qiagen) from the 50 ng or 60 ng/ml puromycin screens fol-
lowing ten days under selection, and from the 70 ng/ml
screen after 23 days under selection. The genomic DNA
from library cells grown in the absence of tetracycline or
puromycin was harvested after either three or ten days of
growth.
RIT-seq (RNA interference target sequencing) was car-
ried out as previously described (31). Briefly, the remaining
RNAi target fragments in each selected RNAi library were
PCR amplified using LIB2f and LIB2r primers as described
in (34). The amplified products were sequenced on an Il-
lumina MiSeq platform (BGI Genomics). Sequence reads
containing the RNAi construct-specific 14-base barcode
were identified using a custom script (34). Mapping was car-
ried out using Bowtie2 (35) set to ‘very sensitive local’ align-
ment, and output SAM files were processed using SAM-
tools (36). The resultant BAM files were viewed against
the reference genome in the Artemis genome browser (37).
RNAi target fragment read numbers were converted to
RPKM (reads per kilobase per million reads mapped) to ac-
count for interlibrary read depth variations when compar-
ing sequencing outputs from independently selected RNAi
libraries.
Immunofluorescence microscopy
In order to visualise target proteins using antibodies, cells
were washed twice in cold PSG buffer and fixed in 2%
formaldehyde for 15 minutes at room temperature. Fixed
cells were washed twice in PBS and settled on ColorFrost
Plus microscopy slides (Shandon) for 30 min in a humid-
ity chamber. Cells were then permeabilised using 0.1% NP-
40 and then subsequently incubated with the following pri-
mary antibodies: A rabbit polyclonal anti-GFP antibody
(Abcam, Ab290) and anti-Ty epitope mouse monoclonal
BB2 (kind gift of the Keith Gull lab). The secondary anti-
bodies used were: goat anti-rabbit IgG (H+L) conjugated
with Dylight 488, or goat anti-mouse IgG (H+L) conju-
gated to Dylight 594 (both from ThermoFisher Scientific).
Cells were then mounted in Vectashield with DAPI (Vec-
tor Laboratories) and imaged on a Zeiss M1 Imager mi-
croscope with an AxioCam MRm camera. Post-acquisition
analyses were carried out using ImageJ with the BAR plug-
in for quantitation of signal intensity (NIH, Bethesda, MD,
USA). Sample preparation for visualisation of telomeres
using DNA FISH was carried out as detailed above, al-
though instead of antibodies, the DAKO Telomere PNA
FISH kit/FITC (Agilent) was used according to the manu-
facturer’s instructions.
Chromosome immunoprecipitation (ChIP) experiments
ChIP analysis of TbSAP and histone H3 was carried out as
described in (38) and (22) with minor modifications. T. bru-
cei TbSAP-eGFP/TbSAP KO or untagged SM221pur cells
were cross-linked with 1% formaldehyde for 1 h at room
temperature before the reaction was quenched by glycine
addition to a final concentration of 125 mM. Cross-linked
cells were sonicated (BioRuptor, Diagenode) to obtain an
average DNA fragment size of 200 bp. Immunoprecipita-
tion was carried out by incubation at 4◦C for 18 h with anti-
GFP (Ab290, Abcam) or anti-histone H3 (Ab1791, Abcam)
antibodies bound to Protein G magnetic Dynabeads (Ther-
moFisher). Dynabeads without bound antibodies were in-
cluded as controls for all ChIP experiments. ChIP material
was analysed by qPCR (Applied Biosystems 7500 real time
PCR machine) using Brilliant II SYBR low ROX master
mix as previously described (38) and (22) using the primers
listed in Supplementary Table S3. Quantitation of target
sequence enrichment in the ChIP material was calculated
from the percentage of input chromatin after normalisation
by subtraction of the value obtained from the no-antibody
controls.
Flow cytometry analysis
In order to quantitate levels of eGFP fluorescence following
TbSAP RNAi, 1–3 × 106 T. brucei cells were washed twice
in cold PSG and fixed with 2% formaldehyde. Fixed cells
were then washed and resuspended in PBS. In order to de-
termine the percentage of live or dead cells following either
PFR2 or TbSAP RNAi, 0.5–1.0 × 106 unfixed cells were
washed and resuspended in cold PSG. Propidium iodide
(PI) was added to samples to an end concentration of 10
g/ ml with cells kept on ice to prevent internalisation of PI
through endocytosis. Flow cytometry data was acquired us-
ing a BD LSR Fortessa cell analyser operated by BD FACS
Diva software (BD Biosciences) with 10 000 events recorded
per sample. Post-acquisition analysis of flow cytometry data
was with FlowJo v10 software (BD Biosciences).
qPCR analyses of mRNA transcript levels
Total RNA was extracted using a Qiagen RNeasy Mini
kit with genomic DNA depleted using Turbo DNase (Am-
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transcription with 100 ng of total RNA was carried out
using a Qiagen Omniscript RT kit with random hexamers
from Promega. Generated cDNA was diluted 10-fold and
the equivalent of 0.5 ng of RNA was used as the template
for the qPCR reactions. qPCR reactions were carried out
using an Applied Biosystems 7500 real time PCR machine
using Brilliant II SYBR low ROX master mix (Agilent) with
primers listed in Supplementary Table S4.
Mass spectrometry analysis of cell surface GPI-anchored
proteins
Approximately 4 × 107 T. brucei cells per sample were
washed twice at 4◦C in trypanosome dilution buffer (5 mM
KCl, 80 mM NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2
mM NaH2PO4, 20 mM glucose pH 7.6) and resuspended
in 45 l cold 10 mM sodium phosphate buffer (pH 8.0)
with protease inhibitors. Samples were then incubated for
5 min at 37◦C in order to activate endogenous GPI-specific
phospholipase C (GPI-PLC) which cleaves GPI-anchored
proteins on the cell surface (39). Samples were then cooled
on ice and the supernatant was harvested and diluted with
NuPAGE LDS sample buffer (ThermoFisher) and dithio-
threitol to a final concentration of 1× sample buffer with
100 mM dithiothreitol. Harvested proteins were denatured
at 70◦C for 10 min and then frozen before processing for
mass spectrometry using the protocol described in (40).
RNA-seq of bloodstream form T. brucei after induction of Tb-
SAP RNAi
Total RNA was extracted using a Qiagen RNeasy Mini
kit and genomic DNA was depleted using Turbo DNase
(Ambion). Quality of extracted RNA was determined
by agarose gel electrophoresis and TapeStation (Agilent)
analysis. Generation of Illumina-indexed RNA-seq li-
braries and sequencing (HiSeq 4000, Illumina) was carried
out at the BRC Genomics facility (Imperial College
London). RNA-seq libraries were generated by polyA-
enrichment for mRNA and strand selection. Paired-end
sequencing was carried out to a read length of 75 bp at
each end, resulting in approximately 13 million pairs of
reads for each sample. Reads were processed using Trim
Galore v0.4.4 (www.bioinformatics.babraham.ac.uk;
-q28––illumina––stringency 3––length 50––max
n10––trim-n––paired–trim1) and aligned to reference
sequence using bowtie2v2.3.4 (41) (–no-mixed––no-
discordant-I50-X 500). Alignment was performed against
the long-read based assembly of the T. brucei 427 genome
(427 2018; v42). For comparative analysis to a previously
published metacyclic transcriptome (42), reads from study
SRP103532 (www.ebi.ac.uk/ena/) were remapped to the
427 long-read assembly with the parameters above.
Total transcript abundance was assessed using HT-
Seq v0.5.4 (43) considering only fragments mapping with
MAPQ≥2 (to discriminate between ES copies). Differen-
tial expression was estimated using edgeR package (44),
using the ‘RLE’ method for calculation of normalisation
factors, an estimate of dispersion robustified against out-
liers, and fitting count data to a quasi-likelihood negative
binomial generalised log-linear model [glmQLFit method].
To compare transcriptomic changes due to TbSAP RNAi
to those in the metacyclic transcriptome, databases were
remapped to the long-read assembly of the T. brucei 427
genome (v46 based on the work of (45)) as above. Read
depth analysis was performed using bedtools v2.25.0 (46).
Alternatively, the RNA-seq reads were mapped to the T.
brucei 427 genome and expression comparison was carried
out using DEseq.
RESULTS
A genome-scale RNAi library screen identifies a putative
MES repressor protein
In order to identify novel repressors of the silent meta-
cyclic VSG expression sites (MES) of bloodstream form T.
brucei, we performed genome-scale RNAi library screens.
These have previously successfully elucidated novel regula-
tory pathways in African trypanosomes (47–49). We first
generated the bloodstream form T. brucei SM221 MES-
Pur reporter strain, which expresses VSG221 from the
VSG221 bloodstream form expression site (BES1) (Figure
1A, Supplementary Figure S1A). We inserted a reporter
construct containing a puromycin resistance gene immedi-
ately downstream of the inactive metacyclic VSG expres-
sion site (MES) VSG653 promoter (10) (42). As we could
not select for construct integration using the repressed MES
VSG653 promoter, we included an ectopic ribosomal DNA
(rDNA) promoter directing expression of a blasticidin resis-
tance gene downstream of the silent puromycin resistance
gene (Figure 1A).
The MES repressor RNAi library screen involved intro-
ducing a plasmid library containing fragments of the entire
T. brucei genome cloned between opposing tetracycline in-
ducible T7 promoters into the T. brucei SM221 MES-Pur
reporter strain (33). Use of the rare cutting homing endonu-
clease I-SceI, allowed high efficiency targeting of the plas-
mid library to rDNA spacers (50). Knockdown of a putative
MES repressor through the induction of RNAi with tetra-
cycline would result in derepression of the normally inac-
tive MES VSG653 promoter, and increased puromycin re-
sistance of the selected trypanosomes. Readthrough tran-
scription from the MES located ectopic rDNA promoter
in the SM221 MES-Pur strain resulted in increased expres-
sion of MES VSG653 transcript (Supplementary Figure
S1B). However, introduction of the construct did not result
in significantly increased transcription from the endoge-
nous MES VSG653 promoter, as the relative puromycin re-
sistance of the T. brucei SM221 MES-Pur strain was ap-
proximately equivalent to that of the parental T. brucei
SM221 cells (50–100 ng/ml puromycin) (Supplementary
Figure S1C).
We therefore performed the MES repressor RNAi library
screen three times using three different concentrations of
puromycin (50, 60 and 70 ng/ml) in order to select at dif-
ferent degrees of stringency and thereby increase chances
of success (Figure 1B). First, we electroporated the RNAi
library into SM221 MES-Pur cells, generating a T. brucei
RNAi library with an estimated 6.3x coverage of the hap-
loid T. brucei genome. RNAi was induced with tetracycline
at time point 0, and cells were subsequently placed on se-
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Figure 1. A whole genome RNAi library screen designed to identify repressors of metacyclic expression site (MES) transcription in bloodstream form T.
brucei. (A) Schematic of the T. brucei SM221 MES-Pur cell line with a marked MES used for conducting the screen. A puromycin resistance gene (Pur) was
inserted immediately downstream of the endogenous promoter (white flag) of the VSG653 (purple box) MES. A downstream blasticidin resistance gene
(Blast) expressed from an ectopic rDNA promoter (black flag) allowed selection for construct integration. A putative MES repressor protein is indicated
with a red dot, various genes with coloured boxes, telomere repeats with horizontal arrows and transcription with a dashed arrow. After transfection of
a tetracycline inducible whole genome RNAi library, the cell line was placed on different levels of puromycin selection to select for derepression of the
inactive MES promoter after the induction of RNAi with tetracycline. (B) Cumulative growth curve of T. brucei RNAi library cells in the presence (+)
or absence (−) of tetracycline (Tet) to induce RNAi in the presence of different levels of puromycin (Pur) selection. Tetracycline was added at day 0, and
puromycin selection at day 1 (arrow). The growth curve shows the cumulative number of cells through time in the presence (+) or absence (−) of tetracycline
and puromycin. (C) Venn diagram of shared MES repressor candidates identified from high throughput RITseq (100 read equivalent RPKM cutoff) from
the 50, 60 and 70 ng/ml puromycin (Pur) selection screens. (D) Correlation plot of mapped reads from RITseq data from tetracycline induced trypanosome
libraries selected with either 50 ng/ ml or 60 ng/ml puromycin (pur). Each dot represents a single T. brucei gene. The minimum threshold of 100 reads is
marked by red dotted lines, and genes with <100 reads in both screens shown in dark grey, and genes with at least 100 reads in both screens shown in green.
Correlation between the reads obtained with either the 50 or 60 ng/ml screens is high (Pearson correlation coefficient R2 = 0.985). TbSAP (Tb927.10.4440)
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tetracycline and puromycin (–Tet, 0 ng/ml Pur) grew at a
normal rate (Figure 1B). Cells in the presence of puromycin
but no tetracycline to induce RNAi died.
RNAi library induction and selection in 50 or 60 ng/ml
puromycin, led to reduced growth for seven days, followed
by the emergence of a resistant population. In the presence
of 70 ng/ml puromycin, growth retardation was more pro-
nounced, with a resistant population only emerging at day
19. Genomic DNA was harvested when each library had
achieved a consistent robust growth rate (Figure 1B), and
the remaining RNAi target fragments were amplified, us-
ing RNAi construct-specific primers (Supplementary Fig-
ure S2A).
RIT-seq (RNA interference target sequencing) was car-
ried out to identify the RNAi target fragments enriched
after puromycin selection. The PCR-amplified RNAi tar-
get fragments were deep sequenced, generating >3 mil-
lion sequence reads per selected RNAi library, of which
16–24% contained the RNAi construct barcode. Barcode-
containing reads were mapped against the T. brucei 927
reference genome and read values were converted to reads
per kilobase per million reads mapped (RPKM) to account
for read depth variations between the sequenced RNAi li-
braries. High confidence hits were identified as those rep-
resented by RPKM equivalent to >99 reads containing
the RNAi construct barcode. Selection in 50 or 60 ng/ml
puromycin followed a similar growth profile and identified a
highly similar set of genes (Pearson’s correlation coefficient
of R2 = 0.985) (Figure 1C, D).
In contrast, selection in 70 ng/ml puromycin resulted in
delayed emergence of a resistant population and a substan-
tially greater number of apparent hits, which showed little
concordance with those identified following selection in 50
or 60 ng/ml puromycin (Pearson’s correlation coefficients of
R2 = 0.104 or R2 = 0.102 respectively) (Supplementary Fig-
ure S2B, C). We initially assumed that selection in 70 ng/ml
puromycin would enhance the stringency of our screen.
However, the delayed recovery time and the large number
of hits identified, suggests that secondary adaptations oc-
curred in a founder population, enabling a proportion of
cells to survive in the presence of puromycin, independent
of specific RNAi library-mediated knockdown, thereby re-
ducing the stringency of the screen. Hence, while selection
in 70 ng/ml puromycin identified some hits also seen fol-
lowing selection in 50 and/or 60 ng/ml puromycin, none
of the 364 unique hits were investigated further. Forty eight
hits were identified following selection in 50 and 60 ng/ml
puromycin, of which 14 were also identified following selec-
tion in 70 ng/ml puromycin (Figure 1C, Supplementary File
S1). Remarkably, no genes were identified that had been pre-
viously documented to play a role in the repression of BESs
(reviewed in (13)), suggesting that in bloodstream form T.
brucei MES silencing is mechanistically fundamentally dif-
ferent to the silencing of BESs.
Most of the proteins identified following puromycin se-
lection of our MES Pur RNAi library have no obvious
connection with transcriptional regulation, suggesting that
rather than derepressing the MES PUR gene expression,
they may influence puromycin action (either directly or in-
directly), with their depletion reducing T. brucei drug sensi-
tivity. However, of the 14 hits identified in all three screens,
Tb927.10.4440 stood out as the only protein with a known
nuclear localisation (Tryptag.org; (51); (Supplementary File
S1). This protein contains a predicted SAP DNA binding
domain (InterPro) (Figure 2A), a 35 residue motif consist-
ing of two parallel -helices connected by an extended loop
(52).
The SAP motif was first identified on the scaffold at-
tachment factors A and B (SAF-A and SAF-B), and was
later found on a range of proteins involved in nucleic acid
metabolism (53). It was postulated that this SAP motif
could target proteins to specific chromosomal locations. In
addition, both SAP as well as the related LEM motif, were
proposed to be involved in tethering chromatin to the nu-
clear periphery, thereby impacting on chromosomal organ-
isation within the nucleus (52). As this, and Tb10.v4.0034
(which is identical at the amino acid level) are the only pro-
teins in the T. brucei genome matching a SAP domain profile
(e value < 1e–3), we named it TbSAP, and focused on it for
further investigation.
TbSAP is a nuclear protein enriched at ES promoters and
MESs
We first determined the cellular localisation of TbSAP by
epitope tagging the N-terminus with eGFP in bloodstream
form T. brucei using CRISPR-Cas9 (27,54). We validated
correct epitope tagging of an endogenous TbSAP gene us-
ing PCR (data not shown). As fluorescence signal from the
eGFP tagged TbSAP protein was weak, we performed im-
munofluorescence microscopy using anti-GFP antibodies
(Figure 2B). TbSAP had a heterogeneous distribution in
the nucleoplasm, but was particularly enriched in foci at the
nuclear periphery. These results correspond with the cellu-
lar localisation of TbSAP in procyclic form T. brucei docu-
mented by the TrypTag initiative (TrypTag.org).
Telomeres in bloodstream form T. brucei are particularly
enriched at the nuclear periphery (55,56). Our attempts at
combining TbSAP localisation with DNA fluorescence in
situ hybridisation (FISH) to visualise T. brucei telomeres
were unsuccessful. We therefore tested for colocalisation of
TbSAP with the T. brucei TTAGGG-binding factor (TRF).
TbTRF protein binds telomeres, and plays an important
role in telomere biology, including suppressing VSG switch-
ing mediated by DNA rearrangements (57–59). We there-
fore epitope tagged TbTRF at the N-terminus with the Ty
epitope in cells containing an allele of TbSAP which was
endogenously tagged with eGFP. Immunofluorescence mi-
croscopy experiments visualising both TbTRF and TbSAP
at the same time showed that TbSAP foci were often adja-
cent to TbTRF foci, but we did not see obvious colocalisa-
tion of the two proteins (Figure 2C). We do not think that
the N-terminal addition of eGFP to TbSAP in bloodstream
form T. brucei compromised its function, as knocking out
the second TbSAP allele in these cells using CRISPR/Cas9
was successful (Supplementary Figure S3A). This did not
alter the cellular localisation of the epitope tagged TbSAP,
and as expected, nuclear staining of TbSAP was enriched at
the nuclear periphery (Supplementary Figure S3B). In addi-
tion, even though tagging one allele of SAP with eGFP led
to a slight reduction in growth compared with the parental






/nar/advance-article/doi/10.1093/nar/gkab109/6154463 by guest on 05 M
arch 2021
Nucleic Acids Research, 2021 7
Figure 2. TbSAP is a protein with a canonical SAP domain which is enriched at the nuclear periphery of bloodstream form T. brucei. (A) Schematic of
TbSAP (Tb927.10.4440) with a canonical SAP domain indicated with a pink box and disordered domains with red boxes as determined using InterPro.
The predicted SAP domain of TbSAP is aligned with SAP motifs from Homo sapiens (Hs) SAF-A, SAF-B, Acinus and PIAS1 proteins using T-coffee
(http://tcoffee.crg.cat/apps/tcoffee/). Conserved amino acid residues are highlighted in green, and helical domains with pink cylinders as predicted using
PSIPRED. (B) Enrichment of TbSAP at the nuclear periphery is shown in representative nuclei of bloodstream form T. brucei expressing a SAP-eGFP
fusion protein from the endogenous TbSAP locus. DNA was visualised with DAPI and GFP using an anti-GFP antibody. Pixel intensity of each colour
along a profile (white dashed line) was calculated using the ImageJ BAR multi-plot analysis tool, with the blue line indicating DAPI stained DNA and the
green line SAP-GFP. The white scale bar indicates 5 m. (C) TbSAP foci do not obviously colocalise with regions enriched for the telomere binding protein
TbTRF. Representative nuclei (1K1N) of a T. brucei cell line containing one allele of TbSAP tagged with eGFP and one allele of TbTRF tagged with a
10X Ty1 epitope are shown. SAP-GFP is visualised with an anti-GFP antibody (green), TbTRF with an anti-Ty1 antibody (red) and DNA is stained with
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of the second SAP allele (Supplementary Figure S3C). This
argues that the SAP-GFP protein was not functionally im-
paired to a very significant extent.
As the SAP motif is a DNA binding domain, we deter-
mined the distribution of TbSAP-GFP on T. brucei DNA
using chromatin immunoprecipitation (ChIP). As TbSAP-
GFP was functional, we performed the ChIP experiments
in the T. brucei TbSAP-GFP/ TbSAP KO cells. The ChIP
experiments were also performed in the parental T. brucei
SM221pur-Cas 9 cell line as a negative control (Figure 3).
Unfortunately, we were never able to isolate enough anti-
GFP-TbSAP ChIP enriched DNA to perform ChIP-seq.
We therefore analysed the TbSAP-ChIP enriched DNA us-
ing qPCR. We first determined the distribution of TbSAP
over MES VSG653 (Figure 3A). MES sequences are di-
vergent from each other, and we were not able to use uni-
versal primer pairs to analyse TbSAP distribution over all
MESs. However, a low but significant level of TbSAP was
detected at the MES VSG653, with higher levels observed at
the MES promoter (primer b) (*P < 0.05) (Figure 3B upper
panel). TbSAP was also detected at the VSG gene in MES
VSG653 (primer c), as well as the VSG in MES VSG397
(primer d). Histone H3 was also immunoprecipitated in par-
allel ChIP experiments as a control, and showed an approx-
imately equivalent distribution in both cell lines (Figure 3B
lower panel).
We next determined the distribution of TbSAP over the
15 BESs of T. brucei 427, which contain large stretches
of highly similar DNA sequence (Figure 3C) (12). A sig-
nificant enrichment of TbSAP was observed in the region
immediately upstream of the BES promoters (*P < 0.05)
(primers a–c in Figure 3D, upper panel), with negligible
binding of TbSAP to BES downstream regions. More Tb-
SAP appeared to be immunoprecipitated on DNA from
the vicinity of BES compared with MES promoters. This
is presumably as the BES promoter primers recognise ∼20
highly conserved BES promoters, compared with the MES
VSG653 primers which identify single copy sequence. Again
as a control, the distribution of histone H3 was determined
in both T. brucei cell lines, which as expected, was enriched
on silent BES5 sequences and depleted on active BES2 se-
quences (Figure 3D, lower panel). The distribution of Tb-
SAP over the Pol I transcribed rDNA and Pol II tran-
scribed actin loci was also determined (Supplementary Fig-
ure S4A). There was some TbSAP observed within the 20
rDNA transcription units, with reduced levels detected in
the rDNA spacers presumably reflecting the relative diver-
gence of these sequences compared with the conserved 18S
and 28S rDNA genes. Negligible amounts of TbSAP were
found at the constitutively transcribed actin Pol II loci (Sup-
plementary Figure S4B). As a control, the distribution of hi-
stone H3 was determined, which is particularly enriched in
nontranscribed regions (Supplementary Figure S4C) (60).
TbSAP knockdown leads to MES derepression in blood-
stream form T. brucei
We next determined the essentiality of TbSAP, and repro-
ducibility of MES derepression following TbSAP knock-
down. We constructed a reporter cell line with an eGFP
gene inserted immediately downstream of the inactive MES
VSG653 promoter (Figure 4A). Construct integration was
selected for using a downstream blasticidin resistance gene
driven by an ectopic rDNA promoter. Tetracycline in-
ducible TbSAP RNAi was expressed from a construct con-
taining a stem–loop fragment for TbSAP inserted at a sin-
gle copy VSGG4 (VSG-31) gene present at a T. brucei mini-
chromosome (28). The induction of TbSAP RNAi with
tetracycline resulted in a severe reduction in growth after
about 24 h, but there was no evidence for a discrete cell cycle
arrest (Figure 4B). There was a minor amount of cell death,
but the majority of cells were alive after 96 h (Figure 4C), in-
dicating that the knockdown of TbSAP resulted in reduced
growth rate rather than acute lethality. Quantitation of Tb-
SAP transcript using qPCR confirmed that the induction
of TbSAP RNAi resulted in its reduction to ∼40% normal
levels after 72 h (Figure 4D).
In order to determine the effect of TbSAP knockdown
on the bloodstream form T. brucei transcriptome, we per-
formed RNA-seq after the induction of TbSAP RNAi for
72 h. As TbSAP was identified in a screen for MES repres-
sors, we first investigated if we had induced a global shift
to a more ‘metacyclic-like’ cell. We compared the blood-
stream form transcriptome after the induction of TbSAP
RNAi for 72 h with the transcriptome from the parental
MES-GFP strain (X-axis of Figure 5). In addition, we
compared the available transcriptome from in vitro derived
metacyclic T. brucei 427 cells with the parental MES-GFP
strain, which was remapped to the same assembly (Y-axis of
Figure 5) (42). Transcripts which were significantly changed
specifically in metacyclic forms are indicated with red dots,
and those which have specifically changed after the induc-
tion of TbSAP RNAi are indicated with blue dots. Tran-
scripts which are significantly changed in both transcrip-
tomes compared with the parental cells are indicated with
pink dots.
As expected, eight metacyclic VSGs were significantly
upregulated in the metacyclic transcriptome (green circles)
(Figure 5A). The induction of TbSAP RNAi resulted in
significant derepression of seven of these different meta-
cyclic VSGs (green circles). The most significantly upreg-
ulated transcripts observed both after the induction of Tb-
SAP RNAi for 72 h in bloodstream form T. brucei, as well
as in the metacyclic transcriptome, were metacyclic VSGs.
However, we did not find that that knocking down Tb-
SAP with RNAi made the cell generally more ‘metacyclic-
like’, and both induced and non-induced samples cluster to-
gether distinct from the metacyclic transcriptome in princi-
pal component analysis (Figure 5B). This argues that Tb-
SAP knockdown results in derepression of MES telomeres
within cells which still fundamentally have a bloodstream
form transcriptome.
When looking at the changes in the transcriptome ob-
served after the knock-down of TbSAP for 72 h, there is
a strong bias towards transcript upregulation rather than
downregulation (Figure 6). In total, 397 transcripts were
upregulated using a cut-off value of a 1.4-fold increase and
an adjusted P-value of ≤ 0.1 (Supplemental file S2). In
contrast, only 25 transcripts were downregulated using the
same threshold. Strikingly, the degree of dysregulation was
also much stronger for the genes with increased transcript
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Figure 3. TbSAP is enriched at the promoter regions of metacyclic and bloodstream form ESs. (A) Schematic of a telomeric metacyclic ES (MES) with the
promoter indicated with a white flag and the metacyclic VSG653 gene with a purple box. Primer pairs used for analysis of chromatin immunoprecipitated
(ChIP) material are indicated with lettered bars. Primer pair ‘c’ recognises VSG653 and primer pair ‘d’ recognises VSG397 present within a different MES.
(B) The level of SAP-GFP present at MESs in the SAP-GFP/SAP KO line (green bars), which has one allele of TbSAP epitope tagged with eGFP, and the
other TbSAP allele knocked out. In comparison, the same ChIP was performed with the parental cell line (T. brucei SM221 Pur-Cas9) (red bars) which does
not contain epitope tagged TbSAP. In the top graph the ChIP was performed with an anti-GFP antibody. In the lower graph ChIP was performed using
anti-histone H3 antibodies. Results are presented as the percentage of the total input immunoprecipitated after subtraction of a no antibody control. Data
for the ChIP experiments is the mean of three biological replicates, with the standard deviation indicated with error bars. Statistical significance (pair-wise
t-test against ChIP material from the untagged parental SM221pur cells) is indicated with asterisks (*P < 0.05). (C) Schematic of bloodstream form ES
(BES1) with a puromycin resistance gene (blue box) inserted behind the active BES1 promoter (white flag). Expression site associated genes (ESAG) 7 and
6 are indicated with numbered boxes, and VSG221 with a red box. Simple sequence repeats (50 or 70 bp) are indicated with vertically striped boxes. An
enlargement of the BES promoter region is indicated below. Primer pairs a–e (indicated with bars) are conserved across all BESs, while primer pairs f-h
are specific for sequences present within either the active BES1 (VSG221, primer pair ‘f ’ and puromycin, primer pair ‘g’) or the silent BES5 (VSG800 or
VSG-18, primer pair ‘h’) respectively. (D) The ChIP experiments were performed as detailed in panel (B) only the distribution of SAP-GFP or histone H3
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Figure 4. RNAi mediated depletion of TbSAP results in a reduction in growth rate with minimal lethality in bloodstream form T. brucei. (A) Schematic
of the SM221pur MES-eGFP reporter cell line which expresses VSG221 from BES1, and which is selected for with a puromycin resistance gene (Pur).
An eGFP gene was inserted immediately downstream of the endogenous MES VSG653 promoter (white flag). The construct was selected for using a
downstream blasticidin gene (Blast) driven by an ectopic rDNA promoter (black flag). Transcription is indicated with arrows. A TbSAP stem-loop RNAi
construct containing a tetracycline inducible T7 promoter (grey flag) was inserted into a locus containing the single copy minichromosomal VSGG4 gene
(28). (B) Cumulative growth curve for two MES-eGFP TbSAP RNAi clones (c1 and c2) in the presence (+) or absence (−) of tetracycline (Tet) to induce
TbSAP RNAi. Time is indicated in hours (h). The mean of three biological replicates is shown with standard deviation indicated with error bars. (C)
Determination of live/ dead bloodstream form T. brucei cells stained with propidium iodide and analysed by flow cytometry after the induction of TbSAP
RNAi for the time indicated. Data for clone c1 are shown with error bars representing the standard deviation from three biological replicates. Tests for
significance (t-test) show slightly increased lethality after induction of TbSAP RNAi compared with time 0, with statistically significant results indicated
with **P < 0.01 and ***P < 0.001. (D) Quantitation of TbSAP transcript with qPCR after induction of TbSAP RNAi for the time indicated in hours
(h). Data from clone c1 are shown with error bars representing the standard deviation from three biological replicates. Statistical significance for the
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Figure 5. Comparison of the TbSAP RNAi transcriptome with a previously published metacyclic transcriptome reveals that although the induction of
TbSAP RNAi results in the upregulation of metacyclic VSGs, this does not lead to ‘metacyclic-like’ cells. (A) Transcripts are indicated with dots, with
changes in expression level after the induction of TbSAP RNAi for 72 h relative to uninduced parental cells (MES-GFP), shown on the X-axis. This is
plotted against differential expression of transcripts in the metacyclic form (MCF) transcriptome described in (42) compared with parental MES-GFP
cells on the Y-axis. Differentially expressed genes in either comparison (adjusted P-value ≤ 0.05) are highlighted. Transcripts which are only differentially
expressed in the metacyclic form transcriptome are indicated in maroon. Transcripts which are only significantly changed after the induction of TbSAP
RNAi for 72 h are indicated in blue. Transcripts which are significantly changed in both transcriptomes are indicated in pink, with MES VSGs indicated
with green circles. Transcripts which have not significantly changed with respect to the transcriptome of the parental cells are indicated with grey circles. (B)
Principal component analysis of sample to sample distances of the metacyclic form (MCF), parental (MES-GFP) or TbSAP RNAi (MES-GFP TbSAP)
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Figure 6. Knock-down of TbSAP leads to striking up-regulation of both VSGs and ESAGs with relatively few downregulated transcripts. (A) Volcano
plot showing differential gene expression after induction of TbSAP RNAi for 72 h compared with the parental T. brucei MES-GFP cell line. Dots indicate
individual transcripts with those corresponding to MES VSGs indicated in light orange. Results are plotted as log2 (fold change) of read count values versus
adjusted P-value. Thresholds at adjusted P-value ≤0.1 and fold change ≥1.4 are shown (dashed lines). Values were calculated from three biological replicates
of each dataset. The other panels are as in (A), only in panel (B) VSGs located in BESs are highlighted with dark orange dots, panel (C), chromosome
internal (CI) VSGs located within the silent VSG arrays are highlighted with purple, panel (D) VSGs located on minichromosomes are indicated with pink
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at fdr ≤0.1, compared to 1.2-fold for downregulated genes).
This is suggestive of a predominant role for TbSAP in si-
lencing genomic regions in T. brucei.
A striking number of VSGs in different genomic loca-
tions were upregulated, as were transcripts from Expres-
sion Site Associated Genes (ESAGs) found in BESs (Fig-
ures 6, 7A, Supplemental file S2). Of eight VSGs in T. brucei
427 genome assemblies sited <4 kb downstream of a puta-
tive MES promoter, seven were upregulated between 6.5-
and 18.5-fold after TbSAP knockdown (Figures 6A, 7A,
Supplementary Table S5). The eighth MES VSG was MES
VSG653, which is the site of integration of the reporter con-
struct, and which was upregulated to a lesser extent. A fur-
ther putative metacyclic VSG, VSG-631, is a long distance
from a possible MES promoter (8.9 kb), and was not differ-
entially expressed in the RNA-seq experiments. In contrast
to VSGs in MESs, none of the 14 VSGs located in BESs,
were significantly differentially expressed (Figure 6B).
Significantly, knockdown of TbSAP causes a substantial
upregulation of transcripts from silent subtelomeric VSG
arrays (chromosome internal, or CI) VSGs (Figure 6C). In
total, 121 of 2875 CI VSGs (4.2%) are significantly changed
at the thresholds used, compared to 230 of 14 196 non-VSG,
non-ES genes (1.6%, P <10–15; proportions test). CI VSG
transcripts increase from 4.6 to 5% of total VSG transcripts
in the parental or uninduced cell lines to 6.9% after the in-
duction of TbSAP RNAi for 72 h (Figure 7A). In contrast,
none of the VSGs located on the T. brucei minichromo-
somes appeared to be significantly upregulated after the in-
duction of TbSAP RNAi (Figure 7D). Although there was
no significant upregulation of VSGs located in BESs, signif-
icant upregulation of ESAGs located in BESs was observed
(Figure 6E).
However, a concern was that the derepression of both
silent VSGs from the VSG arrays, and ESAGs was exclu-
sively a secondary consequence of compromised transcrip-
tion in sick cells. To resolve this, we determined the tran-
scriptome of cells where RNAi against -tubulin had been
induced for 16 h as a lethality control. The induction of
RNAi against -tubulin results in an abrupt growth arrest,
with disruption of cytoskeletal structures and cells unable to
undergo cytokinesis (61). In spite of ablation of TbSAP hav-
ing a much weaker effect on cell growth, more chromoso-
mal internal VSGs from the VSG arrays (CI VSG) were up-
regulated after induction of TbSAP RNAi compared with
after induction of -tubulin RNAi (Supplementary Figure
S5A). We did not find a correlation between which VSG
transcripts were upregulated after both perturbations (Pear-
son’s coefficient R2 = 0.0017). A similar trend was found for
the ESAG transcripts although the degree of upregulation
was less (Supplementary Figure S5B).
To confirm the derepression of MES VSGs seen in the
RNA-seq, we analysed RNA levels by quantitative RT-PCR
(qPCR) (Figure 7B). We observed that all eight T. brucei 427
MES VSGs were significantly derepressed after 72 h of Tb-
SAP RNAi. Highest were MES VSG636 with 25.6 ± 7.7-
fold upregulation (**P ≤ 0.01), MES VSG1954 with 16.8
± 3.2-fold (***P ≤ 0.001) and MES VSG397 with 16.2 ±
3.0-fold upregulation (***P ≤ 0.001) (Supplementary Ta-
ble S5). The MES VSG653 which contained the reporter
construct was only upregulated 2.1 ± 0.1 fold after knock-
down of TbSAP. This SM221pur MES-GFP cell line ex-
presses relatively high levels of VSG653 as a consequence of
readthrough transcription from the exogenous rDNA pro-
moter integrated upstream of the telomeric VSG653 (Sup-
plementary Figure S6A, B). These relatively high back-
ground levels possibly influence the amount of derepres-
sion observed. In agreement with the qPCR quantitation
of the VSG653 transcript, levels of fluorescence from the
eGFP gene inserted upstream of the ectopic rDNA pro-
moter within this MES also showed only 1.4–1.6-fold in-
crease after SAP knockdown (Supplementary Figure S6C).
It is likely that the genetic modification of this MES im-
pacted its ability to be derepressed.
A concern with these MES derepression experiments, is
that the upregulation of MES VSGs was a secondary con-
sequence of cells responding to the reduction in cell growth
rather than a phenotype specific to TbSAP. We therefore
investigated if there was derepression of MES VSGs after
knockdown of the essential gene T. brucei PFR2 (62). As
expected, induction of RNAi against PFR2 led to a very
abrupt growth arrest within 8 h induction of PFR2 RNAi,
with PFR2 transcript reduced to ∼30% normal levels after
induction of PFR2 RNAi for 16 h (Supplementary Figure
S7A–C). Despite the rapid lethality observed after knock-
down of the highly essential PFR2, there was little signifi-
cant increase in metacyclic VSG transcripts, with the possi-
ble exception of MES VSG531 and MES VSG1954 where
we observed only a very marginal increase in transcript
(Supplementary Figure S7D). This argues that the increase
in MES VSG transcripts observed after the induction of Tb-
SAP RNAi is indeed a specific phenotype related to TbSAP
rather than a secondary effect.
Derepression of BES promoters and chromosome internal
VSGs after TbSAP knockdown
VSGs at the telomeres of the BESs were not significantly
derepressed after knockdown of TbSAP. However, the BES
ESAGs, particularly those closest to the BES promoters
(ESAGs 10, 7 and 6), were derepressed to a greater extent
(Figure 8A, B). This indicates that although knockdown of
TbSAP leads to derepression of the BES promoters, this
transcription is not fully processive. We next investigated
the derepressed transcription observed after TbSAP knock-
down at a whole genome level (Figure 9, Supplementary
Figure S8). The T. brucei 427 genome contains 11 diploid
megabase chromosomes with extensive polycistronic tran-
scription units containing house-keeping genes (2). After
SAP knockdown, we did not see an increase in transcripts
either within or at the strand-switch regions of the poly-
cistronic Pol II transcription units (Figure 9, Homo. core).
The silent VSG arrays comprise one of the few non-
transcribed regions in African trypanosomes, and are
present as extensive single copy stretches at the arms of the
diploid megabase chromosomes (45,63). In several regions
of the silent VSG arrays, SAP knockdown led to an increase
in inappropriate transcription of silent VSG genes (Figure
9, Hetero. arm). There are not thought to be Pol II pro-
moters in these regions. However, it is possible that a re-
pressive chromatin structure prevents activation of cryptic
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Figure 7. Knockdown of TbSAP results in significant upregulation of metacyclic VSGs in bloodstream form T. brucei. (A) Relative abundance of VSG
transcripts following RNAi against TbSAP for 72 h. Only transcripts other than VSG221 (VSG-2), present in the active BES1 are shown. The MES with
mVSG-653 is the site of integration of the reporter construct. High levels of MES VSG-653 expression are due to the ectopic rDNA promoter which has
been introduced in the construct. Abundance is shown as a percentage of the total VSG transcript reads. (B) Depletion of TbSAP leads to significant up-
regulation of all eight MES VSGs. RT-qPCR was performed using RNA isolated from cells where TbSAP RNAi had been induced with tetracycline (Tet)
for the time indicated in hours (h). Values were normalised against actin and shown as fold-change relative to the uninduced sample. Values plotted are
the mean of three independent experiments with the standard deviation indicated with error bars. Statistical significance for upregulation was determined
using Student’s t-test (*P < 0.05, **P < 0.01, ***P < 0.001).
VSG arrays after the induction of TbSAP RNAi indicates
that TbSAP could be playing a role in maintenance of a re-
pressed chromatin state in these silenced areas of the T. bru-
cei genome.
TbSAP RNAi mediated MES derepression produces func-
tional mVSG proteins
We next investigated if these upregulated VSGs were present
on the trypanosome cell surface, indicating functionality.
Bloodstream form T. brucei expresses an endogenous phos-
pholipase C (PLC) which can be activated in trypanosomes
in vitro, where it cleaves membrane bound VSG at the GPI
anchor, releasing a soluble form of VSG (39). We performed
quantitative proteomics to determine the relative amounts
of different VSGs in soluble VSG fractions following the
induction of TbSAP RNAi. In the T. brucei SM221 MES-
Pur cell line expressing VSG221 from the active BES1, MES
VSG653 comprises 1.3% total VSG protein (Figure 10A).
As mentioned earlier, this high expression level of VSG653
is presumably a consequence of readthrough from the ec-
topic rDNA promoter (Supplementary Figure S1). If a Tb-
SAP RNAi construct is introduced into this cell line, the
amount of MES VSG653 increases about three fold (pre-
sumably as a consequence of leaky transcription of the
RNAi fragment), and then further increases after the induc-
tion of TbSAP RNAi (Figure 10A).
For the other MES VSGs, the proteomic analyses glob-
ally reflect what was observed at the transcript level. Meta-
cyclic VSGs with the highest transcript reads (VSG397,
VSG531, VSG636 and VSG1954) were all detected by mass
spectrometry following phospholipase-C cleavage, indicat-
ing localisation on the cell surface (Figure 10B). Although
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Figure 8. Differential upregulation of promoter proximal expression site associated genes (ESAGs) in bloodstream form expression sites (BESs) after the
induction of TbSAP RNAi. (A) Schematic of a typical telomeric BES with promoters indicated with white flags and relevant expression site associated
genes (ESAGs) or pseudogenes () with numbered coloured boxes (12). 70 bp repeat arrays are indicated with a vertically hatched box. (B) Differential
regulation of ESAGs in inactive BESs following induction of TbSAP RNAi for 72 h. ESAGs have been arranged according to their common conserved
position in T. brucei 427 BESs (12). A Tukey boxplot is shown with median (bar), interquartile range (box) and inner fences (whiskers) for all transcripts
resulting from individual ESAGs of each family, excluding those of the active BES1. Only transcripts directed with MAPQ ≥2 at ≥1 reads per million
reads are included (one transcript each of inactive ESAG12 and ESAG8 copies pass this threshold). Asterisks indicate Bonferroni-corrected P-values for
individual transcript sets being different from 0 (Student’s t-test; *** P ≤ 0.001, ** P ≤ 0.01, * P ≤ 0.05).
parental VSG221 cells, after the induction of TbSAP RNAi
for 72 or 96 h, they comprise 0.35% or 0.54% of the total
VSG protein respectively. Less protein was detected from
VSGs present in either the chromosome internal VSG ar-
rays or BESs than would be expected from the transcript
reads. These results show that if MESs are derepressed, they
can produce functional VSG protein in bloodstream form
T. brucei.
DISCUSSION
Recently progress has been made in identifying factors in-
volved in BES repression in bloodstream form T. brucei
including a range of chromatin proteins and remodelers
(13). In addition, VEX1 was identified using whole genome
RNAi screens, and VEX2/CAF1B through determining the
VEX1 interactome (65,66). However, it is still not under-
stood how all MESs are kept transcriptionally silent in
bloodstream form T. brucei.
Here, using whole genome RNAi library screens, we iden-
tified a novel SAP DNA binding domain containing protein
(TbSAP) which plays an important role in MES repression
in bloodstream form T. brucei. We found that TbSAP is en-
riched at the nuclear periphery of bloodstream form try-
panosomes, and using ChIP, established that TbSAP binds
both MESs and the immediate region upstream of the BES
promoters. Knockdown of TbSAP resulted in significant
upregulation (up to 26-fold) of the silent MESs. However,
these bloodstream form cells depleted of TbSAP retained
a bloodstream form transcriptome rather than becoming
‘metacyclic’-like, indicating that TbSAP was not affecting
T. brucei differentiation. Strikingly after knockdown of Tb-
SAP, most of the transcripts with changed levels of expres-
sion were upregulated (397 transcripts) rather than down-
regulated (25 transcripts). The upregulated transcripts in-
cluded VSGs within the inactive chromosome internal sub-
telomeric VSG arrays, which are not within transcription
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Figure 9. Increased transcription of silent VSGs present within the silent VSG sub-telomeric arrays after the induction of TbSAP RNAi for 72 h in MES-
eGFP TbSAP RNAi cells. Transcript levels (mean fragment count over three replicates) in the presence (+) of TbSAP RNAi (red line) or absence (−) of
TbSAP RNAi (black line) were mapped over the T. brucei megabase chromosomes. Below the traces gene architecture is shown, with housekeeping genes
indicated with grey bars, and silent VSGs with blue bars. Magnified detail is presented from regions within chromosomes (Chr.) 4, 6, 8 and 9. These include
regions within the silent VSG arrays present at the heterozygous transcriptionally silent aneuploid chromosomal arms (Hetero. arm). Alternatively, these
regions are within the homologous transcriptionally active diploid chromosomal cores (Homo.core). In order to display on the log scale, counts of 0 have
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Figure 10. Multiple up-regulated VSGs are present on the cell surface fol-
lowing the induction of TbSAP RNAi (A) Quantitative proteomic analysis
using mass spectrometry of surface VSGs cleaved by release of endogenous
GPI-PLC after hypotonic lysis. Samples are from the parental VSG221 ex-
pressing SM221pur MES-GFP cells (MES-GFP) or cells where TbSAP
RNAi has been induced with tetracycline (Tet) for the time indicated in
hours (h). VSG221 expressed from the active BES1 is omitted from the
BES VSGs dataset, as it displayed an abundance of 95–99% in each sample.
In these cell lines MES VSG653 is expressed from readthrough transcrip-
tion from an ectopic rDNA promoter introduced upstream of the VSG653
gene. The different classes of VSGs are indicated with coloured bars, with
MES VSG653 indicated with a blue bar, other MES VSGs (purple), BES
VSGs (green bar) or VSGs in chromosome internal (CI) silent VSG arrays
(black). Data are the mean of three biological replicates. (B) As in panel (A)
only both MES VSG653 and VSG221 are omitted from the VSG dataset,
as together they made up >99% of the sample. Different types of VSGs
(present in either MESs or BESs) are indicated with coloured bars, with
VSGs not located in ESs indicated as CI VSGs (grey and black bars). Data
are the mean of three biological replicates.
of ESAGs within the immediate vicinity of the silent BES
promoters. All of these data argue that in bloodstream form
T. brucei, TbSAP could be a repressive chromatin protein,
which plays a key role in maintaining a transcriptionally in-
active state at genomic regions containing silent VSGs.
Knockdown of TbSAP resulted in derepression of both
MES and BES promoters, despite the fact that BES pro-
moters are 30–60 kb upstream of the chromosome end
compared with MES promoters which are normally in
the immediate proximity (1–2 kb) of the telomeric VSG
(10,12). However, derepression of BES promoters predom-
inantly resulted in only limited transcription immediately
downstream of the promoters comparable to what was ob-
served after knocking down the ISWI and FACT complexes
(67,68) or the histone chaperones ASF1A/ CAF1B (69).
It is likely that derepressed elongating RNA polymerases
are hindered by a RAP1 mediated silencing gradient ex-
tending upwards from the inactive BES telomeres of blood-
stream form T. brucei preventing fully processive transcrip-
tion (70,71).
Although knockdown of TbSAP led to some derepres-
sion of BES promoters, our RNAi library screens selecting
for MES repressors did not identify any of the known BES
repressors (reviewed in (13)). This argues that repression of
MESs is mechanistically different from the repression of in-
active BESs in bloodstream form T. brucei. The immediate
vicinity of the BES telomere (within several kb of the telom-
ere repeats) is more stringently silenced than upstream sub-
telomeric regions in bloodstream form T. brucei (72). As the
MES transcription units are normally within 5 kb of the
telomere end, it is possible that they are all kept repressed
by this localised telomeric silencing gradient in bloodstream
form T. brucei. In contrast, BES promoters, which are nor-
mally 30–60 kb upstream of the telomere repeats, would be
expected to be out of range of this localised telomeric re-
pression. It would be interesting to determine the nature of
the telomeric silencing gradients operating in metacyclic T.
brucei, where MES monoallelic exclusion operates, and only
one MES escapes silencing in any given cell.
TbSAP is the only SAP domain containing protein iden-
tifiable in the T brucei genome. The SAP DNA binding do-
main comprises a two-helical bundle which was first found
on the scaffold attachment proteins SAF-A and SAF-B,
which bind chromosomal nuclear scaffold attachment re-
gions (SARs) (73,74). SARs are discrete AT-rich DNA ele-
ments, which are thought to allow compartmentalisation of
the eukaryotic genome into different regions of chromatin
through chromosomal attachment to the nuclear scaffold.
The SAP DNA binding motif was subsequently found on
nuclear proteins with diverse roles including transcription,
DNA repair and RNA processing. The broad range of func-
tions of these SAP domain containing proteins, suggest that
the SAP domain along with other elements present in each
of these proteins may dictate their distinct functionality.
Both the SAP domain found in unicellular and multicel-
lular eukaryotes, and the highly related LEM motif found
exclusively in metazoans, are present on proteins tethering
chromatin to the nuclear lamina (52). Compatible with a
role in silencing telomeres, TbSAP was enriched at the nu-
clear periphery, possibly sequestering genomic areas con-
taining silent VSGs to this region of low transcriptional ac-
tivity. Although the heterogeneous distribution of SAP at
the nuclear periphery was reminiscent of telomeric clusters,
we did not see obvious colocalisation of TbSAP with the T.
brucei telomere binding protein TbTRF. In addition, we did
not find evidence that knockdown of TbSAP led to redistri-
bution of T. brucei telomeres within the nucleus, as inves-
tigated using telomere DNA-FISH. However, most of the
telomeric signal in these experiments was presumably de-
rived from the telomeres of the ∼100 mini-chromosomes,
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mosomes (55,75). It remains possible that TbSAP specifi-
cally tethers MES and BES containing telomeres to the nu-
clear periphery, however, this remains to be investigated.
RNA-seq following TbSAP knockdown with RNAi re-
vealed that BES derepression occurred primarily in pro-
moter proximal regions. This corresponds with the ChIP
experiments showing association of TbSAP with both MES
and BES promoters. In addition, we found that transcripts
from VSGs within the silent subtelomeric VSG arrays were
upregulated. The T. brucei genome appears to be compart-
mentalised into different chromatin domains. Using Hi-C
chromosome conformation capture approaches, the Siegel
lab has argued that the T. brucei genome is partitioned
within the nucleus, with the silent subtelomeric VSG ar-
rays folded into distinct highly compact regions (45). While
silent BESs appear to be enriched at the nuclear periphery
in bloodstream form T. brucei, the active BES appears to
be internal in the nucleus. This cellular localisation of silent
BESs appears to affect transcriptional control. Knockdown
of the T. brucei NUP1 and NUP2 proteins, which associate
with the nuclear periphery, affects transcriptional repres-
sion of ESs as well as the localisation of telomeres (76,77).
It is possible that TbSAP has a similar effect on inactive ES
telomeres. The observation that TbSAP is present in foci,
which are adjacent to, but not colocalised with TbTRF foci
at the nuclear periphery, would be compatible with enriched
binding of TbSAP to these condensed subtelomeric regions
of the genome.
The silent VSG arrays, which are located at the sub-
telomeres of megabase chromosomes, contain thousands
of silent VSGs, (45). Additionally, 100–200 VSGs are lo-
cated at the telomeres of minichromosomes, which are pri-
marily comprised of palindromic arrays of 177 bp sim-
ple sequence repeat, and have a different nuclear distribu-
tion as well as segregating differently to megabase chro-
mosomes (55,75,78). Knockdown of TbSAP resulted in in-
creased transcript levels of VSGs present within the silent
VSG arrays but not the VSGs at minichromosomes. Whole
genome nucleosome positioning analyses, have shown that
the silent VSG arrays do not have precisely positioned nu-
cleosomes, but are flanked upstream and downstream by
extensive regions of chromatin with well positioned nucle-
osomes (64). These bordering regions of chromatin poten-
tially prevent readthrough from upstream Pol II transcrip-
tion units into the silent VSG arrays. In addition, the silent
VSG arrays are likely to have more compact chromatin than
the core regions of the housekeeping chromosomes, which
would prevent fortuitous transcription initiation from cryp-
tic Pol II promoters (45). It is possible that TbSAP functions
as a repressive chromatin protein suppressing activation of
cryptic promoter sequences, and unwanted transcription of
the many thousands of silent subtelomeric VSG genes. The
lack of derepression of minichromosomal VSGs upon Tb-
SAP knockdown could be a consequence of the simple se-
quence structure of the minichromosomes. As they are pri-
marily comprised of simple sequence repeats, this would
presumably restrict the number of regions potentially func-
tioning as cryptic promoters if the chromatin state of these
minichromosomes became less repressive.
TbSAP was recently identified in procyclic T. brucei as
one of several interacting partners of SNF2PH, a SUMOy-
lated transcription factor enriched at the telomere of the
active BES in bloodstream form T. brucei (Appendix Ta-
ble S2 in (79)). In addition to TbSAP, other SNF2PH inter-
acting partners identified included transcription regulating
factors including Spt16 of the FACT complex and the Pol
I transcription factor CITFA-4 (68,80). The functional sig-
nificance of this association of TbSAP with SNF2PH is un-
clear, especially as these results were obtained in procyclic
form T. brucei, which was not studied here. However, it is
compatible with the observation that both proteins bind up-
stream of BES promoters as seen using ChIP experiments
in this study and in Figure 3 in (79).
In conclusion, TbSAP appears to be a DNA binding pro-
tein suppressing transcription of MESs and BESs as well
as VSGs at the silent VSG arrays in bloodstream form T.
brucei. The enrichment of TbSAP at the nuclear periph-
ery combined with the RNA-seq and ChIP data are con-
sistent with a model whereby association of TbSAP with
the promoters of silent ESs at the nuclear periphery en-
ables transcriptional suppression. Whether this is mediated
through regulation of gene localisation, or through changes
in global chromatin architecture in these regions is still un-
clear. In agreement with a proposed global silencing func-
tion, knockdown of TbSAP led to significant upregulation
rather than downregulation. TbSAP knockdown led to sig-
nificant derepression of MESs, but the derepressed cells re-
tained a bloodstream form transcriptome. This novel fac-
tor therefore gives us additional insight into one of the lay-
ers of control allowing bloodstream form T. brucei to keep
the silent MESs as well as the many thousands of silent
VSGs transcriptionally inactive. In addition, it gives us in-
sight into how repressed genomic regions are kept silent in
an early branching eukaryote, where most of the genome is
transcriptionally active.
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